Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FGFR2 |
Variant | K292M |
Impact List | missense |
Protein Effect | no effect - predicted |
Gene Variant Descriptions | FGFR2 K292M lies within Ig-like C2-type domain 3 of the Fgfr2 protein (UniProt.org). K292M has not been biochemically characterized, but results in similar cell proliferation and viability levels as wild-type Fgfr2 in cultured cells (PMID: 29533785), and therefore, is predicted to have no effect on Fgfr2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
FGFR2 mutant FGFR2 exon7 FGFR2 K292M |
Transcript | NM_000141.5 |
gDNA | chr10:g.121520043T>A |
cDNA | c.875A>T |
Protein | p.K292M |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001320658 | chr10:g.121520043T>A | c.875A>T | p.K292M | RefSeq | GRCh38/hg38 |
NM_001320658.2 | chr10:g.121520043T>A | c.875A>T | p.K292M | RefSeq | GRCh38/hg38 |
NM_001320654.2 | chr10:g.121500827_121500828delAAinsTG | c.875_876delAAinsTG | p.K292M | RefSeq | GRCh38/hg38 |
NM_001144917 | chr10:g.121520043T>A | c.875A>T | p.K292M | RefSeq | GRCh38/hg38 |
NM_000141 | chr10:g.121520043T>A | c.875A>T | p.K292M | RefSeq | GRCh38/hg38 |
NM_001320658.1 | chr10:g.121520043T>A | c.875A>T | p.K292M | RefSeq | GRCh38/hg38 |
NM_000141.5 | chr10:g.121520043T>A | c.875A>T | p.K292M | RefSeq | GRCh38/hg38 |
NM_001320654.1 | chr10:g.121500827_121500828delAAinsTG | c.875_876delAAinsTG | p.K292M | RefSeq | GRCh38/hg38 |
NM_022970 | chr10:g.121520043T>A | c.875A>T | p.K292M | RefSeq | GRCh38/hg38 |
NM_001144917.1 | chr10:g.121520043T>A | c.875A>T | p.K292M | RefSeq | GRCh38/hg38 |
NM_001144913 | chr10:g.121520043T>A | c.875A>T | p.K292M | RefSeq | GRCh38/hg38 |
NM_000141.4 | chr10:g.121520043T>A | c.875A>T | p.K292M | RefSeq | GRCh38/hg38 |
NM_001320654 | chr10:g.121500827_121500828delTTinsCA | c.875_876delAAinsTG | p.K292M | RefSeq | GRCh38/hg38 |
NM_001144913.1 | chr10:g.121520043T>A | c.875A>T | p.K292M | RefSeq | GRCh38/hg38 |
NM_001144917.2 | chr10:g.121520043T>A | c.875A>T | p.K292M | RefSeq | GRCh38/hg38 |
NM_022970.3 | chr10:g.121520043T>A | c.875A>T | p.K292M | RefSeq | GRCh38/hg38 |
NM_022970.4 | chr10:g.121520043T>A | c.875A>T | p.K292M | RefSeq | GRCh38/hg38 |
NM_001144913.1 | chr10:g.121520043T>A | c.875A>T | p.K292M | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|